EASI p‐EASI: Predicting disease severity in atopic dermatitis patients treated with cyclosporin A
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- EASI p-EASI: Utilizing a combination of serum biomarkers offers an objective measurement tool for disease severity in atopic dermatitis patientsJournal of Allergy and Clinical Immunology, 2017
- An Integrated Model of Atopic Dermatitis Biomarkers Highlights the Systemic Nature of the DiseaseJournal of Investigative Dermatology, 2017
- Biomarkers for atopic dermatitisCurrent Opinion in Allergy and Clinical Immunology, 2015
- What the Eczema Area and Severity Index score tells us about the severity of atopic dermatitis: an interpretability studyBritish Journal of Dermatology, 2015
- A panel of biomarkers for disease severity in atopic dermatitisClinical & Experimental Allergy, 2015
- Utility of serum thymus and activation-regulated chemokine as a biomarker for monitoring of atopic dermatitis severityJournal of the American Academy of Dermatology, 2014